🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

35+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 15 of 35 recruiting trials for “endometrial-stromal-sarcoma”

Phase 2RecruitingNCT05385549 ↗

5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk

🏥 Asan Medical Center📍 1 site📅 Started Sep 2022View details ↗
Phase 1RecruitingNCT05489237 ↗

First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

🏥 IDRx Inc. - A GSK Company📍 30 sites📅 Started Aug 2022View details ↗
RecruitingNCT05461664 ↗

Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA

👨‍⚕️ Xinhua Zhang, PhD, First affiliated hosptial,Sun Yat-sen university📍 1 site📅 Started Jul 2022View details ↗
RecruitingNCT05464875 ↗

A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors

👨‍⚕️ Xinhua Zhang, PhD, First affiliated hosptial,Sun Yat-sen university📍 1 site📅 Started Jul 2022View details ↗
RecruitingNCT05440357 ↗

Second-line Pharmacotherapy Patterns and Outcomes of Advanced Gastrointestinal Stromal Tumor: A Real-world Study

👨‍⚕️ zhang xinhua, PhD, First affiliated hosptial,Sun Yat-sen university📍 8 sites📅 Started Jul 2022View details ↗
Phase 2RecruitingNCT05152472 ↗

A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments

👨‍⚕️ Mehdi BRAHMI, MD, Centre Leon Berard📍 13 sites📅 Started Jan 2022View details ↗
Phase 2RecruitingNCT05009927 ↗

Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten)

👨‍⚕️ Jean-Yves BLAY, Pr, Centre Léon Bérard, Lyon📍 13 sites📅 Started Jan 2022View details ↗
RecruitingNCT05408897 ↗

Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD

👨‍⚕️ Yingjiang Ye, Peking University People's Hospital📍 1 site📅 Started Jan 2022View details ↗
Phase 2RecruitingNCT04933669 ↗

Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors

👨‍⚕️ Jiren Yu, Zhejiang University📍 1 site📅 Started Sep 2021View details ↗
Phase 2RecruitingNCT03624244 ↗

Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)

👨‍⚕️ Isabelle RAY-COQUARD, MD PhD, Centre Leon Berard📍 22 sites📅 Started Jan 2019View details ↗
RecruitingNCT03602092 ↗

Observational Registry Data on GIST Patients

👨‍⚕️ Tsang-Wu Liu, M.D, Taiwan Cooperation Organization Group,NHRI,Taiwan📍 1 site📅 Started Oct 2018View details ↗
RecruitingNCT03716089 ↗

Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable Site

🏥 Fujian Medical University📍 1 site📅 Started Oct 2018View details ↗
Phase 1RecruitingNCT03594422 ↗

A Study of HQP1351 in Patients With GIST or Other Solid Tumors

👨‍⚕️ Ruihua Xu, Professor, Sun Yat-sen University📍 6 sites📅 Started Jul 2018View details ↗
RecruitingNCT01048281 ↗

Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

👨‍⚕️ James M Ford, Stanford University📍 1 site📅 Started Aug 2002View details ↗
RecruitingNCT00005095 ↗

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

👨‍⚕️ Lee P. Shulman, MD, Robert H. Lurie Cancer Center📍 1 site📅 Started Mar 2000View details ↗
← PreviousPage 2 of 2

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →